ArticleACS sensors2025
Using Machine Learning and Optical Microscopy Image Analysis of Immunosensors Made on Plasmonic Substrates: Application to Detect the SARS-CoV-2 Virus.
Article in ACS sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Multifunctional Nanomaterials for Precision Diagnostics and Drug Delivery: AI-Assisted Biosensing, Barrier-Directed Transport, Stimuli-Responsive Release, and Theranostic Integration.Molecules (Basel, Switzerland) · 2026Review
- Advances and Challenges in Wearable Sensors for Health Monitoring.ACS applied materials & interfaces · 2026Review
- Artificial Intelligence-Assisted Pathogen Detection: Algorithms, Biosensing Platforms, and Applications.Biosensors · 2026Review
- Conundrums of Localized Surface Plasmon Resonance Biosensors.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Deep Learning-Enhanced Nanozyme-Based Biosensors for Next-Generation Medical Diagnostics.Biosensors · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, we introduce a diagnostic platform comprising an optical microscopy image analysis system coupled with machine learning. Its efficacy is demonstrated in detecting SARS-CoV-2 virus particles at concentrations as low as 1 PFU (plaque-forming unit) per milliliter by processing images from an immunosensor on a plasmonic substrate. This high performance was achieved by classifying images with the support vector machine (SVM) algorithm and the MobileNetV3_small convolutional neural network (CNN) model, which attained an accuracy of 91.6% and a specificity denoted by an F1 score of 96.9% for the negative class. Notably, this approach enabled the detection of SARS-CoV-2 concentrations 1000 times lower than the limit of detection achieved with localized surface plasmon resonance (LSPR) sensing using the same immunosensors. It is also significant that a binary classification between control and positive classes using the MobileNetV3_small model and the random forest algorithm achieved an accuracy of 96.5% for SARS-CoV-2 concentrations down to 1 PFU/mL. At such low concentrations, straightforward screening of newly infected patients may be feasible. In supporting experiments, we verified that texture was the main contributor to the distinguishability of images taken at different SARS-CoV-2 concentrations, indicating that the combination of ML and image analysis may be applied to any biosensor whose detection mechanism is based on adsorption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.